Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK315234 synovial biomarker placebo-controlled study in rheumatoid arthritis
NL-OMON34936Phase 2Not yet recruiting
- Sponsor
- GSK
- Start
- Mar 2010
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of GSK315234 in rheumatoid arthritis (RA), sponsored by GSK. Planned start Mar 2010; status: not yet recruiting.
02
Drugs
GSK315234
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NL-OMON34936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34936.